Leqembi Five-Year Data Shows Sustained Benefit in Early Alzheimer's
Published 2 d ago1 sourceEvidence: Reported
Researchers are investigating whether GLP-1 weight-loss medications may have cognitive or neuroprotective benefits beyond metabolic effects. Current findings are preliminary and far from conclusive, with no established causal link to memory protection. This matters as it could expand the therapeutic scope of a major drug class, but no market-moving data is yet available.
AI disclosure: Model-written summary of the source, not a verified fact. Check the sources. How Mosaic works
Published 2 d ago1 sourceEvidence: Reported
Published 3 d ago1 sourceEvidence: Reported
Published 22 h ago1 sourceEvidence: Reported
Published 18 h ago1 sourceEvidence: Reported
Published 2 d ago1 sourceEvidence: Reported
Published 6 h ago2 sourcesEvidence: Reported
Published 2 d ago2 sourcesEvidence: Reported
Published 2 d ago2 sourcesEvidence: Reported